Clinical Trial Update: Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term immunogenicity and safety of an HPV vaccine in healthy female subjects has completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus-related Diseases
• Papillomavirus Infection

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus, Papillomavirus Vaccines | Phase 3 | Status: COMPLETED | Results posted: 2011-04-27